Daily News Podcast

Daily News Special: SABCS

Publish date: January 12, 2019

 

In this special edition of the MDedge Daily News, Nick Andrews and Terry Rudd report the latest news from the 2018 San Antonio Breast Cancer Symposium. Stories include: uUing low-dose tamoxifen, the latest findings from the KATHERINE trial, results of a meta-analysis of neoadjuvant chemotherapy, and capecitabine in early stage triple negative breast cancer.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Low-dose tamoxifen halves recurrence of breast intraepithelial neoplasia
MDedge ObGyn
Nothing to gain from chemo after pCR achieved
MDedge ObGyn
RT of lymph nodes as good as dissection for the long-term
MDedge ObGyn
Tamoxifen at 5 mg halves recurrence of breast intraepithelial neoplasia
MDedge ObGyn
Data underscore the importance of lifestyle interventions in breast cancer patients
MDedge ObGyn
QOL is poorer for young women after mastectomy than BCS
MDedge ObGyn
Older breast cancer patients given adjuvant chemo live longer
MDedge ObGyn
Young women opt for mastectomy even when neoadjuvant chemo works well
MDedge ObGyn
Actionable mutations more likely in women with both breast and uterine cancer
MDedge ObGyn
Managing menopausal vasomotor and genitourinary symptoms after breast cancer
MDedge ObGyn